DUBLIN--(BUSINESS WIRE)-- The "Nosocomial Infections - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

This report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Nosocomial Infections development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Scope

• The report provides a snapshot of the pipeline development for Nosocomial Infections
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for Nosocomial Infections
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Nosocomial Infections
• The report also covers the dormant and discontinued pipeline projects related to Nosocomial Infections

Companies Featured

• Appili Therapeutics
• Cellceutix Corp.
• Debiopharm International SA
• Evaxion Biotech ApS
• F. Hoffmann-La Roche Ltd.
• FOB Synthesis Inc.
• ImmunoClin Corp.
• Kyorin Pharmaceutical Co. Ltd.
• Melinta Therapeutics Inc.
• Nosopharm SAS
• Peptilogics Inc.

Key Topics Covered

1. Report Introduction

2. Nosocomial Infections Overview

3. Pipeline Therapeutics

• An Overview of Pipeline Products for Nosocomial Infections

4. Comparative Analysis

5. Products in Clinical Stage

5.1 Drug Name: Company Name

• Product Description
• Research and Development
• Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

6.1 Drug Name: Company Name

• Product Description
• Research and Development
• Product Development Activities

7. Therapeutic Assessment

• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type

8. Inactive Products

8.1 Drug Name: Company Name

• Product Description
• Research and Development
• Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/4r2674/nosocomial?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181017005378/en/

Report Abuse